Westpac Banking Corp Sells 3321 Shares of AbbVie Inc (ABBV)

Saturday, 13 Jan, 2018

Vanguard Group Inc. now owns 115,920,673 shares of the company's stock worth $8,405,409,000 after acquiring an additional 3,706,941 shares in the last quarter. The institutional investor held 156,454 shares of the prepackaged software company at the end of 2017Q3, valued at $7.57 million, up from 71,846 at the end of the previous reported quarter. Abbvie Inc now has $160.19B valuation. The stock decreased 1.47% or $0.93 during the last trading session, reaching $62.39. The shares were sold at an average price of $90.55, for a total value of $1,657,065.00. (NASDAQ:SVVC) has risen 11.85% since January 13, 2017 and is uptrending. It has underperformed by 6.07% the S&P500. GONZALEZ RICHARD A sold $6.24M worth of stock. Alpha Windward LLC now owns 4,547 shares of the company's stock valued at $287,000 after buying an additional 15 shares during the period. Philadelphia Trust Company who had been investing in John B Sanfilippo & Son for a number of months, seems to be less bullish one the $704.85 million market cap company.

The stock increased 0.69% or $0.11 during the last trading session, reaching $16.03. LSB Industries, Inc. (NYSE:LXU) has declined 34.80% since January 13, 2017 and is downtrending.

Investors sentiment increased to 1.13 in Q3 2017. Its up 0.14, from 1.3 in 2017Q2. 106 funds opened positions while 696 raised stakes. Pillar Pacific Mgmt Ltd Liability Corporation invested 0.19% in AbbVie Inc. Outfitter Advsrs invested in 0.16% or 5,041 shares. Nj State Employees Deferred Compensation Plan stated it has 40,000 shares or 0.64% of all its holdings. Reilly Financial Advsr Limited Liability has 0.28% invested in AT&T Inc. (NASDAQ:TMUS). Moreover, Wexford Cap Lp has 0.17% invested in T-Mobile US, Inc. 17,996 are owned by Laurion Limited Partnership. Apg Asset Management Nv holds 0.45% in Mastercard Incorporated (NYSE:MA) or 1.93 million shares. Cornercap Counsel holds 100,665 shares or 0.68% of its portfolio. Schwab Charles Inv Management, a California-based fund reported 36,690 shares. The Virginia-based Greylin Mangement has invested 0.13% in AT&T Inc. Baystate Wealth Mngmt Ltd Llc invested in 0.02% or 2,738 shares. (NYSE:LXU). Teachers Retirement Sys Of The State Of Kentucky holds 0% in LSB Industries, Inc. Savings Bank Of Stockton invested in 10,586 shares. Seven investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company's stock. Therefore 48% are positive. AT&T Inc. had 68 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of AbbVie Inc. The firm earned "Buy" rating on Thursday, May 25 by Jefferies.

Metropolitan Life Insurance Company increased Ashford Hospitality Trust Reit Inc (NYSE:AHT) stake by 60,992 shares to 121,736 valued at $812,000 in 2017Q3. It also upped Schwab Strategic Tr (SCHV) stake by 94,174 shares and now owns 202,591 shares. (NYSE:T) rating on Monday, April 18. It also increased its holding in Avery Dennison Corp.

Since July 31, 2017, it had 0 insider purchases, and 8 sales for $45.57 million activity. (NYSE:ABBV) shares were sold by Gosebruch Henry O. Shares for $8.57 million were sold by RICHMOND TIMOTHY J. The insider Michael Robert A. sold $589,512. On Monday, September 11 the insider SALEKI-GERHARDT AZITA sold $705,655. Mayo Investment Advisers LLC's holdings in AbbVie were worth $667,000 as of its most recent filing with the Securities & Exchange Commission. (NYSE:ABBV) was sold by Schumacher Laura J.

Mairs & Power INC cut its stake in shares of AbbVie Inc. Therefore 74% are positive. Equities analysts expect that AbbVie Inc. will post $5.48 earnings per share for the current year. On Monday, October 2 the stock rating was upgraded by Leerink Swann to "Outperform". (NYSE:ABBV) earned "Buy" rating by Jefferies on Thursday, May 25. After $1.41 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42 % EPS growth. As per Thursday, September 8, the company rating was downgraded by JP Morgan. Evercore ISI restated an outperform rating and set a $100.00 price target (up from $95.00) on shares of AbbVie in a research note on Saturday, September 30th. The stock now has an average rating of Buy and a consensus target price of $100.94. The company was maintained on Thursday, September 28 by Piper Jaffray. The rating was maintained by BMO Capital Markets with "Hold" on Wednesday, October 11. (NYSE:ABBV) rating on Friday, December 18.

Investors sentiment decreased to 0.85 in 2017 Q3. Its up 0.02, from 1.15 in 2017Q2. It is negative, as 55 investors sold ABBV shares while 640 reduced holdings.

Institutional investors and hedge funds have recently made changes to their positions in the company. Somerset Tru holds 432 shares. Company insiders own 0.23% of the company's stock. Boyd Watterson Asset Mgmt Lc Oh has 1.66% invested in AbbVie Inc. (NYSE:ABBV). 117.95M are held by Vanguard Gru. Moreover, D Scott Neal has 0.12% invested in AbbVie Inc. (NYSE:ABBV). Assetmark stated it has 0.14% in AbbVie Inc. (NYSE:ABBV). Univest Of Pennsylvania invested in 52,160 shares. Finally, Canal Capital Management LLC increased its stake in shares of AbbVie by 0.8% in the third quarter. Zurcher Kantonalbank (Zurich Cantonalbank) has 145,982 shares for 0.08% of their portfolio. Miles Cap Incorporated has 32,484 shares. Advisory Services Limited Liability Company invested in 20,113 shares or 0.11% of the stock. (NYSE:ABBV) for 12,768 shares. Baldwin Investment Mngmt Ltd Liability Corp reported 17,980 shares. Visionary Asset Management has invested 1.1% of its portfolio in AbbVie Inc. (NYSE:T) for 47,611 shares. UBS maintained AbbVie Inc. (NYSE:T) for 42.02 million shares.

Shares of AbbVie Inc.

Several other equities analysts have also issued reports on ABBV. They expect $1.43 EPS, up 19.17% or $0.23 from last year's $1.2 per share. The company has a market cap of $98.35 billion, a PE ratio of 16.67 and a beta of 1.57.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.